ClinicalTrialsFinder

Castration Resistant Metastatic Prostate Cancer Clinical Trials in Clermont-Ferrand

1 recruitingClermont-Ferrand, France

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate Cancer

Castration Resistant Metastatic Prostate CancerTreated by 177Lutetium-PSMA-617 (Lu-PSMA)
Centre Jean Perrin120 enrolled5 locationsNCT06600802